Jocelyne Jacquemier
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 41
- Cancer Genomics and Diagnostics 8
- Oncology top 0.2%
- HER2/EGFR in Cancer Research 22
- Cancer Cells and Metastasis 12
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 15
- Molecular Biology top 1%
- Gene expression and cancer classification 12
- Fibroblast Growth Factor Research 7
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Daniel BirnbaumEmmanuelle Charafe‐JauffretPatrice ViensChristophe GinestierFrançois BertucciGabriela DontuMax S. WichaFlorence Monville
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Jocelyne Jacquemier
106 papers receiving 10.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 4.4k
- Oncology 6.2k
- Pathology and Forensic Medicine 1.7k
- Molecular Biology 4.7k
- Pulmonary and Respiratory Medicine 1.8k
Countries citing papers authored by Jocelyne Jacquemier
This map shows the geographic impact of Jocelyne Jacquemier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyne Jacquemier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyne Jacquemier more than expected).
Fields of papers citing papers by Jocelyne Jacquemier
This network shows the impact of papers produced by Jocelyne Jacquemier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyne Jacquemier. The network helps show where Jocelyne Jacquemier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jocelyne Jacquemier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 9 | |
| 2 | Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors. | 2011 | 15 |
| 3 | 2010 | 210 | |
| 4 | Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancerbreakdown → | 2009 | 575 |
| 5 | 2009 | 122 | |
| 6 | 2009 | 69 | |
| 7 | 2008 | 96 | |
| 8 | 2008 | 28 | |
| 9 | 2006 | 218 | |
| 10 | 2006 | 107 | |
| 11 | 2005 | 174 | |
| 12 | 2005 | 102 | |
| 13 | 2004 | 73 | |
| 14 | 2000 | 58 | |
| 15 | 1998 | 51 | |
| 16 | [Modalities of reading of detection mammographies of the programme in the Bouches-du-Rhône. Results and costs 1990-1995]. | 1997 | 10 |
| 17 | 1994 | 6 | |
| 18 | 1994 | 68 | |
| 19 | 1993 | 131 | |
| 20 | 1990 | 205 |
About Jocelyne Jacquemier
Jocelyne Jacquemier is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 109 papers that have together received 10.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (41 papers), HER2/EGFR in Cancer Research (22 papers), Breast Lesions and Carcinomas (15 papers), Cancer Cells and Metastasis (12 papers), Gene expression and cancer classification (12 papers), Cancer Genomics and Diagnostics (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Fibroblast Growth Factor Research (7 papers). The work is most often cited by research in Cancer Research (4.4k citations), Oncology (6.2k citations) and Pathology and Forensic Medicine (1.7k citations). Jocelyne Jacquemier has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Patrice Viens, Christophe Ginestier, François Bertucci, Gabriela Dontu, Max S. Wicha, Florence Monville, Suling Liu and Celina G. Kleer. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.